Simcor and Staring - a phase IV clinical study of FDA data
Summary:
We study 14,695 people who take Simcor (niacin; simvastatin) or have Staring. No report of Staring is found in people who take Simcor.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
What is Simcor?
Simcor has active ingredients of niacin; simvastatin. It is often used in high blood cholesterol. eHealthMe is studying from 11,604 Simcor users. Check the latest studies of Simcor.
What is Staring?
Staring (a prolonged gaze or fixed look) is found to be associated with 333 drugs and 528 conditions by eHealthMe. Check the latest studies of Staring.
No report is found.
Do you take Simcor and have Staring?
- Check whether Staring is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Simcor:
- Simcor (11,604 reports)
Staring treatments and more:
- Staring (3,091 reports)
How severe was Staring and when was it recovered:
Expand to all the drugs that have ingredients of niacin; simvastatin:
Browse all side effects of Simcor:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Staring:
Browse all the conditions that are associated with Staring:
How the study uses the data?
The study uses data from the FDA. It is based on niacin; simvastatin (the active ingredients of Simcor) and Simcor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Ibuprofen and Revlimid drug interactions for men aged 50-59 - a second ago
- Could Minocycline Hydrochloride cause Hypertension Aggravated? - 2 seconds ago
- Drug interactions of Fluticasone Propionate and Garcinia - 3 seconds ago
- Glaucoma in Losartan, how severe and when it was recovered? - 3 seconds ago
- Could Didanosine cause Blister? - 10 seconds ago
- Oxazepam and Tylenol drug interactions for women aged 20-29 - 14 seconds ago
- Mycophenolate Mofetil and Itchiness for Women aged 30-39 - 20 seconds ago
- Mycophenolate Mofetil and Pruritus for Women aged 30-39 - 20 seconds ago
- Mycophenolate Mofetil and Itching for Women aged 30-39 - 20 seconds ago
- Chest X-Ray Abnormal and drugs of ingredients of bicalutamide - 28 seconds ago